USA - NASDAQ:BTCY - US09074H2031 - Common Stock
ChartMill assigns a Buy % Consensus number of 43% to BTCY. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-11-18 | HC Wainwright & Co. | Reiterate | Neutral |
| 2023-11-20 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2023-07-05 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-02-15 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-07-15 | Maxim Group | Downgrade | Buy -> Hold |
| 2022-07-15 | HC Wainwright & Co. | Maintains | Buy |
| 2022-03-07 | Lake Street | Initiate | Buy |
| 2021-11-23 | HC Wainwright & Co. | Initiate | Buy |
6 analysts have analysed BTCY and the average price target is 4.08 USD. This implies a price increase of 781.02% is expected in the next year compared to the current price of 0.4631.
The consensus rating for BIOTRICITY INC (BTCY) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
The number of analysts covering BIOTRICITY INC (BTCY) is 6.